Your Blood May Impact How Long You Live

Photo of Douglas A. McIntyre
By Douglas A. McIntyre Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Your Blood May Impact How Long You Live

© SARINYAPINNGAM / Getty Images

Doctors can already often predict how long someone will live based on their habits, and sometimes, their genes. Depending on how sick someone is, they may even be able to predict when someone will die within a year. However, these approaches are not always accurate. Additionally, scientists want tests which will give physicians more years to treat sick patients before their conditions become irreversible. It turns out that blood tests may be a new way to pinpoint lifespans early enough to still help people get better.

A new scientific study published in Nature Communications looked at mortality risks in 44,168 people. The people’s age range was from 18 to 109. The authors found 14 biomarkers which circulate in the blood. National Institutes of Health Biomarkers Definitions Working Group defines biomarkers as “objective, quantifiable characteristics of biological processes.” The authors of the Nature Communications paper wrote that tests for these biomarkers may allow doctors to predict the risk of the time when a patient may die to a period which spans five to 10 years. This gives physicians advanced time to treat patients at risk for serious diseases and conditions later in life.

A description of the findings in Medical Daily pointed to the importance of the new research. “For instance, they [doctors] would be able to ascertain if an older adult is healthy enough to have surgery, or help identify those in most need of medical intervention.” The biomarker tools may take lifespan prediction well beyond what are now basic blood tests, blood pressure tests, and cholesterol levels which the authors pointed out have varying value as patients get older. The biomarker tests should be more accurate because they look at many more factors which range from “histidine, leucine, and valine to glucose, lactate, and phenylalanine.” Some of these are markers of longer life, while others point to shorter lifespans. As a reference, these are the states where people live the longest. 

The conclusion of the authors give a reason for optimism about the future of blood tests and their ability to predict health.
“A score based on these 14 biomarkers and sex leads to improved risk prediction as compared [with] a score based on conventional risk factors,” they wrote.  However, as is almost always true with such studies, they also said much more research is needed to confirm their conclusions, at least enough for them to be useful in clinical practice.

 

 

Photo of Douglas A. McIntyre
About the Author Douglas A. McIntyre →

Douglas A. McIntyre is the co-founder, chief executive officer and editor in chief of 24/7 Wall St. and 24/7 Tempo. He has held these jobs since 2006.

McIntyre has written thousands of articles for 24/7 Wall St. He is an expert on corporate finance, the automotive industry, media companies and international finance. He has edited articles on national demographics, sports, personal income and travel.

His work has been quoted or mentioned in The New York Times, The Wall Street Journal, Los Angeles Times, The Washington Post, NBC News, Time, The New Yorker, HuffPost USA Today, Business Insider, Yahoo, AOL, MarketWatch, The Atlantic, Bloomberg, New York Post, Chicago Tribune, Forbes, The Guardian and many other major publications. McIntyre has been a guest on CNBC, the BBC and television and radio stations across the country.

A magna cum laude graduate of Harvard College, McIntyre also was president of The Harvard Advocate. Founded in 1866, the Advocate is the oldest college publication in the United States.

TheStreet.com, Comps.com and Edgar Online are some of the public companies for which McIntyre served on the board of directors. He was a Vicinity Corporation board member when the company was sold to Microsoft in 2002. He served on the audit committees of some of these companies.

McIntyre has been the CEO of FutureSource, a provider of trading terminals and news to commodities and futures traders. He was president of Switchboard, the online phone directory company. He served as chairman and CEO of On2 Technologies, the video compression company that provided video compression software for Adobe’s Flash. Google bought On2 in 2009.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CBOE Vol: 1,568,143
PSKY Vol: 12,285,993
STX Vol: 7,378,346
ORCL Vol: 26,317,675
DDOG Vol: 6,247,779

Top Losing Stocks

LKQ
LKQ Vol: 4,367,433
CLX Vol: 13,260,523
SYK Vol: 4,519,455
MHK Vol: 1,859,865
AMGN Vol: 3,818,618